208370.Kq

The company maintains a strong liquidity position, with a current ratio of 9.15, indicating that it holds significantly more current assets than current liabilities. Its cash and equivalents amount to 9,381,594,510 KRW, and free cash flow stands at 3,701,525,280 KRW, supporting operational flexibility and potential reinvestment. The debt-to-equity ratio is 0.02, suggesting a conservative capital structure with minimal reliance on debt financing.

Profitability metrics reveal a mixed performance. The company's return on equity (ROE) is 5.47%, and return on assets (ROA) is 4.92%, both below the industry median for Advanced Medical Equipment & Technology. The net income of 3,889,027,540 KRW contrasts with an operating loss of -161,563,030 KRW, indicating that non-operating income or gains are driving profitability. Gross profit of 14,998,484,930 KRW suggests strong cost control in production, but the operating loss highlights inefficiencies or high overheads in the core business.

The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic breakdown provided. This lack of diversification may expose the company to regional or sector-specific risks, though the absence of geographic data limits further analysis.

Growth appears to be constrained in the near term, with no significant revenue growth reported in the latest period. The capital expenditure of -1,101,695,260 KRW indicates a net outflow for investments in long-term assets, which may signal expansion or modernization efforts. However, the operating cash flow of 304,754,300 KRW is relatively modest compared to the free cash flow, suggesting that capital expenditures are being funded internally.

Risk factors are currently low, with no immediate liquidity or dilution concerns identified. The company's low debt-to-equity ratio and high cash reserves reduce financial risk. However, the operating loss and reliance on non-operating income raise questions about long-term sustainability. The dilution risk is also low, with no recent or pending share issuances reported.

Recent events include the reporting of a negative EPS of -231.11 KRW, which aligns with the operating loss and suggests that earnings are being driven by non-operating items. No significant filings or transcripts have been disclosed that would indicate major strategic shifts or operational challenges.